A fenfluramine-activated FDG-PET study of borderline personality disorder

Biological Psychiatry

Volumn 47, Issue 6, 1999, Pages 540-547

  Soloff, Paul H ^a   Meltzer, Carolyn C ^a   Greer, Phil J ^a   Constantine, Doreen ^a   Kelly, Thomas M ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Aggression; Borderline personality disorder (BPD); FDG PET neuroimaging; Fenfluramine; Impulsivity; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; FENFLURAMINE; FLUORODEOXYGLUCOSE F 18; PLACEBO; SEROTONIN;

ADULT; AGGRESSION; ARTICLE; BORDERLINE STATE; BRAIN REGION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMAGING; IMPULSIVENESS; MALE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SINGLE BLIND PROCEDURE;

ADOLESCENT; ADULT; BORDERLINE PERSONALITY DISORDER; BRAIN; FEMALE; FENFLURAMINE; FLUORODEOXYGLUCOSE F18; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; PREFRONTAL CORTEX; RADIOPHARMACEUTICALS; SEROTONIN UPTAKE INHIBITORS; SINGLE-BLIND METHOD; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0343484257     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00202-4     Document Type: Article

References (46)

1. Bailey D., Jones T., Spinks T., Gilardi M.C., Townsend D. Noise equivalent count measurements in a neuro-PET scanner with retractable septa. IEEE Trans Med Imaging. 10:1991;256-260.
2. Baxter L.R. Jr, Mazziotta J.C., Phelps M.E., Selin C.E., Guze B.H., Fairbanks L. Cerebral glucose metabolic rates in normal human females versus normal males. Psychiatry Res. 21:1987;237-245.
3. Brown G.L., Ebert M.H., Goyer P.F., Jimerson D.C., Klein W.J., Bunney W.E., Goodwin F.K. Aggression, suicide, and serotonin Relationships to CSF amine metabolites . Am J Psychiatry. 139:1982;741-746.
4. Brown G.L., Goodwin F.K., Ballenger J.C., Goyer P.F., Major L.F. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1:1979;131-139.
5. Coccaro E.F. Impulsive aggression and central serotonergic system function in humans An example of a dimensional brain-behavioral relationship . Int J Clin Psychopharmacol. 7:1992;3-12.
6. Coccaro E.F., Berman M.E., Kavoussi R.J., Hauger R.L. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality disordered men. Biol Psychiatry. 40:1996;157-164.
7. Coccaro E.F., Gabriel S., Siever L.J. Buspirone challange Preliminary evidence for a role for central 5HT-1a receptor function in impulsive aggressive behavior in humans . Psychopharmacol Bull. 26:1990;393-405.
8. Coccaro E.F., Siever L.J., Klar H.M., Maurer G., Cochrane K., Cooper T.B., Mohs R.C., Davis K.L. Serotonergic studies in patients with affective and personality disorders Correlates with suicidal and impulsive aggressive behavior . Arch Gen Psychiatry. 46:1989;587-599.
9. De La Fuenta J.M., Goldman S., Stanus E., Vizuete C., Morlan I., Bobes J., Mendlewicz J. Brain glucose metabolism in borderline personality disorder. J Psychiatr Res. 31:1997;531-541.
10. Friston K.J., Frith C.D., Liddle P.F., Frackowiak R.S.J. Comparing functional (PET) images The assessment of significant change . J Cereb Blood Flow Metab. 11:1991;690-699.
11. Friston K.J., Holmes A.P., Worsley K.J., Poline J.B., Frith C.D., Frackowiak R.S.J. Statistical Parametric Maps in functional imaging A general approach . Hum Brain Mapping. 2:1995;189-210.
12. Fuster J.M. The Prefrontal Cortex Anatomy, Physiology and Neuropsychology of the Frontal Lobe, 2nd ed . 1989;Raven, New York.
13. Gardner D.L., Lucas P.B., Cowdry R.W. CSF Metabolites in borderline personality disorder compared with normal controls. Biol Psychiatry. 28:1990;247-254.
14. Goyer P.F., Andreason P.J., Semple W.E., Clayton A.H., King A.C., Compton-Toth B.A., Schultz S.C., Cohen R.M. Positron-Emission tomography and personality disorders. Neuropsychopharmacology. 10:1994;21-28.
15. Gunderson J.G., Kolb J.E., Austin V. The Diagnostic Interview for Borderlines. Am J Psychiatry. 138:1981;896-903.
16. Hamilton M. A psychiatric rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
17. Kapur S., Meyer J., Wilson A.A., Houle S., Brown G.M. Modulation of cortical neuronal activity by a serotonergic agent A PET study in humans . Brain Res. 646:1994;292-294.
18. Leyton M, Okazawa H, Diksic M, Mzengeza S, Blier P, Paris J, Benkelfat C (1998, December): Brain 5-HT synthesis in patients with borderline personality disorder: Region of interest and statistical parametric mapping analyses. Poster presented at the annual meeting of the American College of Neuropsychopharmacology, Las Croabas, Puerto Rico.
19. Leyton M., Okazawa H., Diksic M., Young S.N., Blier P., Nishizawa S., et al. Rates of serotonin synthesis in impulsive patients with borderline personality disorder. J Psychopharmacol. 11:(suppl A84):1997;335.
20. Linnoila M., DeJong J., Virkkunen M. Monoamines, glucose metabolism and impulse control. Psychopharmacol Bull. 25:1989;404-406.
21. Linnoila M., Virkkunen M., Scheinin M., Nuutila A., Rimon R., Goodwin F.K. Low cerebrospinal fluid 5-hydroxyindolacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 33:1983;2609-2614.
22. Loranger A.W., Susman V.L., Oldham J.M., Russakoff L.M. The personality disorder examination A preliminary report . J Pers Disord. 1:1987;1-3.
23. Malloy P., Bihrle A., Duffy J. The orbitomedial frontal syndrome. Arch Clin Neuropsychol. 8:1993;185-201.
24. Mann J.J., Malone K.M., Diehl D.J., Perel J., Cooper T.B., Mintun M.A. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry. 153:1996;174-182.
25. Mann J.J., Malone K.M., Diehl D.J., Perel J., Nichols T.E., Mintun M.A. Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers. J Cereb Blood Flow Metab. 16:1996;418-426.
26. Martial J., Paris J., Leyton M., Zweig-Frank H., Schwartz G., Teboul E., Thavundayil J., Larue S., Kin N.M.K., Nair N.P. Neuroendocrine study of serotonin function in female borderline personality disorder patients A pilot study . Biol Psychiatry. 42:1997;737-739.
27. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., Fox P.T. Reciprocal limbic-cortical function and negative mood Converging PET findings in depression and normal sadness . Am J Psychiatry. 156:1999;675-682.
28. McBride P.A., Tierney H., DeMeo M., Chen Jaw-Sy, Mann J.J. Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry. 27:1990;1143-1155.
29. Miura S.A., Schapiro M.B., Grady C.L., Kumar A., Salerno J.A., Kozachuk W.E. Effect of gender on glucose utilization rates in healthy humans A positron emission tomography study . J Neurosci Res. 27:1990;500-504.
30. Moss H.B., Yao J.K., Panzak G.L. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry. 28:1990;325-338.
31. New A.S., Trestman R.L., Mitropolulou V., Benishay D., Coccaro E., Siever L.J. Serotonergic function and self injurious behavior in personality disorder patients. Psychiatry Res. 69:1997;17-26.
32. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., de Montigny C., Blier P., Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A. 94:1997;5308-5313.
33. O'Keane V., Maloney E., O'Neill H., O'Connor A., Smith C., Dinan T.G. Blunted prolactin response to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. Br J Psychiatry. 160:1992;643-646.
34. O'Keane M., O'Hanlon M., Webb M., Dinan J. d-fenfluramine/prolactin response throughout the menstrual cycle Evidence for an estrogen-induced alteration . Clin Endocrinol. 34:1991;289-292.
35. Raine D., Buchsbaum M.S., Stanley J., Lottenberg S., Abel L., Stoddard J. Selective reductions in pre-frontal glucose metabolism in murderers assessed with positron emission tomography. Psychophysiology. 29:(suppl 4A):1992;S58.
36. Raine D., Buchsbaum M., LaCasse. Brain Abnormalities in murderers indicated by positron emission tomography. Biol Psychiatry. 42:1997;495-508.
37. Siever L.J., Buchsbaum M.S., New A.S., Spiegel-Cohen J., Wei T., Hazlett E., Sevin E., Nunn M., Mitropoulou M. d,l-Fenfluramine response in impulsive personality disorder assessed with [18-F] fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology. 20:1999;413-423.
38. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured Clinical Interview for DSMIII-R. 1988;American Psychiatric Press, Washington, DC.
39. Talairach J., Tournoux P. Co-Planar Stereotactic Atlas of the Human Brain 3-Dimensional Proportional System: An Approach to Cerebral Imaging . 1988;Thieme Medical Publishers, New York.
40. Traskman-Benz L., Asberg M., Schalling D. Serotonergic function and suicidal behavior in personality disorders. Ann N Y Acad Sci. 487:1986;168-174.
41. Virkkunen M., Nuutila A., Goodwin F.K., Linnoila M. Cerebrospinal fluid metabolite in male arsonists. Arch Gen Psychiatry. 44:1987;241-247.
42. Weinberger D.R. A connectionist approach to the prefrontal cortex. J Neuropsychiatry Clin Neurosci. 5:1993;241-253.
43. Woods R.P., Cherry S.R., Mazziotta J.C. Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr. 16:1992;620-633.
44. Woods R.P., Mazziotta J.C. Automated intersubject image registration. J Cereb Blood Flow Metab. 13:1993;S818.
45. Woods R.P., Mazziotta J.C., Cherry S.R. MRI-PET registration with automated algorithm. J Comput Assisted Tomogr. 17:1993;536-546.
46. Zametkin A.J., Nordahl T.E., Gross M., King A.C., Semple W.E., Rumsey J., Hamburger S., Cohen R.M. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med. 20:1990;1361-1366.